Legal Opinion
Davids v. Novartis Pharmaceuticals Corp.
District Court, E.D. New York
Decided October 9, 2013No. 06-CV-431 (ADS)(WDW)PublishedCited by 7 opinions
1Opinion of the Court
MEMORANDUM OF DECISION AND ORDER
SPATT, District Judge.
On February 1, 2006, Barbara Davids (“Davids”) initiated this action against Novartis Pharmaceuticals Corporation (“Novartis” or the “Defendant”), alleging that the Defendant’s drug Zometa caused her to develop a condition referred to as bisphosphonate-related osteonecrosis of the jaw (“BRONJ”). In this regard, Davids brought causes of action for (1) strict products liability; (2) breach of implied warranty; and (3) negligence. On October 4, 2012, a jury trial was commenced and approximately one month later, on November 2, 2012, the jury…
2Cases cited28 opinions
- BMW of North America, Inc. v. GoreSupreme Court of the United States · 1996
- Bruce C. Shrader v. Csx Transportation, Inc.Court of Appeals for the Second Circuit · 1995
- State Farm Mutual Automobile Insurance v. CampbellSupreme Court of the United States · 2003
- Pacific Mutual Life Insurance v. HaslipSupreme Court of the United States · 1991
- Samuel S. SONG, Plaintiff-Appellant, v. IVES LABORATORIES, INC., Defendant-AppelleeCourt of Appeals for the Second Circuit · 1992
23 more not listed; retrieve them via the Exa API.
3Cited by7 opinions
- Charolette Payne v. Novartis Pharm. Corp.Court of Appeals for the Sixth Circuit · 2014
- Kruszka v. Novartis Pharmaceuticals Corp.District Court, D. Minnesota · 2014
- Kaiser v. Johnson & Johnson & Ethicon, Inc.District Court, N.D. Indiana · 2018
- Rowland v. Novartis Pharmaceuticals Corp.District Court, W.D. Pennsylvania · 2013
- Sinkler v. BerryhillDistrict Court, W.D. New York · 2018
2 more not listed; retrieve them via the Exa API.